*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter - as a primary diagnosis code | T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 7.18 | |
| Readmission Rate (%) | 27.29 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 101,548 | |
| Total Hospitalizations with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 23 | |
| DRG Share of Total Hospitalizations | 0.31 | |
| % of Total ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter in DRG | 65.71 | |
| Avg LOS at DRG | 4.68 | |
| Avg LOS with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 5.0 | |
| Readmission Rate at DRG | 32.74 | |
| Readmission Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | NA | |
| Unplanned Readmission Rate at DRG | 13.79 | |
| Unplanned Readmission Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | NA | |
| Total Medicare payments at DRG | $922,969,291 | |
| Total Medicare payments with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $285,425 | |
| Total Medicare payment per Day at DRG | $1,941 | |
| Total Medicare payment per Day with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $2,482 | |
| Total Medicare payment per Hospitalization at DRG | $9,089 | |
| Total Medicare payment per Hospitalization with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $12,410 | |
| Total Medicare Charges at DRG | $4,727,523,206 | |
| Total Medicare Charges with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $1,131,698 | |
| Avg Charges at DRG | $46,555 | |
| Avg Charges with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $49,204 | |
| Mortality Rate at DRG | 2.95 | |
| Mortality Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | NA | |
| SNF Discharge Rate at DRG | 13.87 | |
| SNF Discharge Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | NA | |
| Home Discharge Rate at DRG | 43.04 | |
| Home Discharge Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 181,637 | ||||
| Total Hospitalizations with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 460 | ||||
| DRG Share of Total Hospitalizations | 0.55 | ||||
| % of Total ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter in DRG | 4.93 | ||||
| Avg LOS at DRG | 7.0 | ||||
| Avg LOS with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 6.83 | ||||
| Readmission Rate at DRG | 32.53 | ||||
| Readmission Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 30.21 | ||||
| Unplanned Readmission Rate at DRG | 19.84 | ||||
| Unplanned Readmission Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 20.59 | ||||
| Total Medicare payments at DRG | $2,845,609,163 | ||||
| Total Medicare payments with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $7,202,089 | ||||
| Total Medicare payment per Day at DRG | $2,237 | ||||
| Total Medicare payment per Day with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $2,293 | ||||
| Total Medicare payment per Hospitalization at DRG | $15,666 | ||||
| Total Medicare payment per Hospitalization with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $15,657 | ||||
| Total Medicare Charges at DRG | $14,794,146,746 | ||||
| Total Medicare Charges with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $35,074,189 | ||||
| Avg Charges at DRG | $81,449 | ||||
| Avg Charges with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $76,248 | ||||
| Mortality Rate at DRG | 25.14 | ||||
| Mortality Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 11.09 | ||||
| SNF Discharge Rate at DRG | 19.06 | ||||
| SNF Discharge Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 25.43 | ||||
| Home Discharge Rate at DRG | 20.69 | ||||
| Home Discharge Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 29.57 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 207: RESPIRATORY SYSTEM DIAGNOSIS WITH VENTILATOR SUPPORT >96 HOURS | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 539,642 | ||||
| Total Hospitalizations with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 257 | ||||
| DRG Share of Total Hospitalizations | 1.64 | ||||
| % of Total ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter in DRG | 2.75 | ||||
| Avg LOS at DRG | 6.42 | ||||
| Avg LOS with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 4.46 | ||||
| Readmission Rate at DRG | 26.55 | ||||
| Readmission Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 31.51 | ||||
| Unplanned Readmission Rate at DRG | 20.01 | ||||
| Unplanned Readmission Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 19.33 | ||||
| Total Medicare payments at DRG | $5,267,842,463 | ||||
| Total Medicare payments with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $2,066,008 | ||||
| Total Medicare payment per Day at DRG | $1,520 | ||||
| Total Medicare payment per Day with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $1,801 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,762 | ||||
| Total Medicare payment per Hospitalization with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $8,039 | ||||
| Total Medicare Charges at DRG | $25,503,568,329 | ||||
| Total Medicare Charges with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $9,301,785 | ||||
| Avg Charges at DRG | $47,260 | ||||
| Avg Charges with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $36,194 | ||||
| Mortality Rate at DRG | 5.62 | ||||
| Mortality Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 19.26 | ||||
| SNF Discharge Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 28.79 | ||||
| Home Discharge Rate at DRG | 39.65 | ||||
| Home Discharge Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 28.02 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 469: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 83,447 | ||||
| Total Hospitalizations with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 140 | ||||
| DRG Share of Total Hospitalizations | 0.25 | ||||
| % of Total ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter in DRG | 1.5 | ||||
| Avg LOS at DRG | 6.32 | ||||
| Avg LOS with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 6.13 | ||||
| Readmission Rate at DRG | 26.61 | ||||
| Readmission Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 24.43 | ||||
| Unplanned Readmission Rate at DRG | 10.75 | ||||
| Unplanned Readmission Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 10.69 | ||||
| Total Medicare payments at DRG | $1,636,094,359 | ||||
| Total Medicare payments with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $2,485,616 | ||||
| Total Medicare payment per Day at DRG | $3,100 | ||||
| Total Medicare payment per Day with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $2,897 | ||||
| Total Medicare payment per Hospitalization at DRG | $19,606 | ||||
| Total Medicare payment per Hospitalization with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $17,754 | ||||
| Total Medicare Charges at DRG | $7,936,043,941 | ||||
| Total Medicare Charges with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $13,829,340 | ||||
| Avg Charges at DRG | $95,103 | ||||
| Avg Charges with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $98,781 | ||||
| Mortality Rate at DRG | 3.79 | ||||
| Mortality Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 52.83 | ||||
| SNF Discharge Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 57.14 | ||||
| Home Discharge Rate at DRG | 9.28 | ||||
| Home Discharge Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 8.57 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 312: SYNCOPE AND COLLAPSE | DRG 885: PSYCHOSES | DRG 480: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | DRG 004: TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITHOUT MAJOR O.R. PROCEDURE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 243,742 | ||||
| Total Hospitalizations with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 112 | ||||
| DRG Share of Total Hospitalizations | 0.74 | ||||
| % of Total ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter in DRG | 1.2 | ||||
| Avg LOS at DRG | 2.84 | ||||
| Avg LOS with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 2.99 | ||||
| Readmission Rate at DRG | 16.31 | ||||
| Readmission Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 15.89 | ||||
| Unplanned Readmission Rate at DRG | 11.3 | ||||
| Unplanned Readmission Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 10.28 | ||||
| Total Medicare payments at DRG | $1,150,233,161 | ||||
| Total Medicare payments with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $471,939 | ||||
| Total Medicare payment per Day at DRG | $1,663 | ||||
| Total Medicare payment per Day with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $1,409 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,719 | ||||
| Total Medicare payment per Hospitalization with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $4,214 | ||||
| Total Medicare Charges at DRG | $6,931,408,244 | ||||
| Total Medicare Charges with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $3,802,963 | ||||
| Avg Charges at DRG | $28,437 | ||||
| Avg Charges with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | $33,955 | ||||
| Mortality Rate at DRG | 0.31 | ||||
| Mortality Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 18.06 | ||||
| SNF Discharge Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 24.11 | ||||
| Home Discharge Rate at DRG | 53.49 | ||||
| Home Discharge Rate with ICD T4275XA - Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter | 49.11 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| RIVERSIDE METHODIST HOSPITAL | 3535 OLENTANGY RIVER RD | COLUMBUS | OH | 43214 | 58 |
| CHRISTIANA CARE WILMINGTON HOSPITAL | 501 W 14TH ST | WILMINGTON | DE | 19801 | 57 |
| SANFORD HEALTH | 801 BROADWAY N | FARGO | ND | 58122 | 55 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. HASRAT KHAN | 801 BROADWAY N | FARGO | ND | 58102 | 12 |
| No | ICD Diagnosis Code | Description |
|---|---|---|
| 1 | G92 | Toxic encephalopathy |
| 2 | I10 | Essential (primary) hypertension |